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Abstract
The development of cell printing is vital for establishing biofabrication approaches as
clinically relevant tools. Achieving this requires bio-inks which must not only be easily
printable, but also allow controllable, reproducible printing of cells. This review outlines the
general principles, current progress, and compares the advantages and challenges for the most
widely used biofabrication techniques for printing cells: extrusion, laser, microvalve, inkjet
and tissue fragment printing. It is expected that significant advances in cell printing will
result from synergistic combinations of these techniques and lead to optimised resolution,
throughput and the overall complexity of printed constructs.
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Introduction
Biofabrication is defined as the production of complex living and non-living biological
products from living cells, biomolecules and biomaterials (Mironov et al. 2009a). An
interdisciplinary technological field drawing from cell and developmental biology,
mechanical engineering and materials sciences, it encompasses a broad range of fabrication
approaches. While some biofabrication techniques have been applied to tissue engineering
(TE) since its inception, an increasing realisation of the importance of developing more
sophisticated fabrication approaches has been reflected in a rapidly growing interest in the
field (Derby 2012).

To understand the need for advanced biofabrication techniques, it is first important to outline
the limitations of conventional approaches. The traditional approach to the fabrication of TE
constructs has been to seed a solid, pre-formed, biodegradable polymeric scaffold with a cell
suspension.. The scaffold is typically highly porous to facilitate mass transfer and cell
incorporation through the bulk. Initially, conventional manufacturing processes including
solution casting, particulate leaching, gas foaming, phase separation, melt molding and freeze
drying were employed to fabricate these scaffolds (Leong et al. 2003; Yeong et al. 2004).
Electrospinning has also been widely adopted as a means to create porous scaffolds with
nano-scale fibrous architecture (Pham et al. 2006). However these methods provide little
control over pore size, geometry, interconnectivity and spatial distribution, i.e. placement of
cells within scaffolds is essentially random.

There remain two key challenges in TE of functional constructs resulting from these
limitations. Firstly, mass transfer and the development of a vascular network within
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constructs is a significant issue (Kaully et al. 2009; Lovett et al. 2009; Novosel et al. 2011).
In vivo, cells reside no more than 200 µm from a blood vessel or capillary that supplies the
cells with oxygen and nutrients, and this supply must be reproduced in engineered constructs
if cell viability and function is to be maintained long term (Rouwkema et al. 2008). Secondly,
seeding a scaffold does not facilitate control over cell-cell contact and tissue architecture,
which are primary determinants of cell behaviour and tissue function (Hurtley 2009). In order
to address these challenges, biofabrication techniques must provide the means to accurately
control cell position and tissue architecture in 3D constructs with microscale precision.

More recently, the modus operandi for solid scaffold biofabrication has shifted significantly
as a result of the proliferation of additive manufacturing (AM). Often referred to as rapid
prototyping or solid free-form fabrication, AM refers to a suite of techniques capable of
layer-by-layer fabrication of 3D objects through computer-aided design (CAD) and/or
computer-aided manufacturing (CAM). AM techniques including 3D printing, selective laser
sintering, fused-deposition modelling (FDM) and stereolithography have all been applied
extensively to the biofabrication of scaffolds for TE applications, as highlighted in several
review papers (Hutmacher et al. 2004; Leong et al. 2003; Peltola et al. 2008; Tsang and
Bhatia 2004; Yeong et al. 2004). These approaches provide precise control over both the
external macrostructure and internal microstructure of scaffolds. Programmable microporosity can therefore be designed to aid in mass transfer throughout constructs and in the
development of a vascular network (Miller et al. 2012). Also, the possibility of integration
between CAD principles and 3D medical imaging (magnetic resonance imaging, computer
tomography) means that scaffolds can potentially be designed to suit an individual patient
(Sun et al. 2004).
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Although the scaffolds can be fabricated with added complexity through these AM
techniques, they are still secondarily seeded with cells.. As such, many of the problems
associated with traditional solid scaffolds, particularly the inability to recapitulate a complex
multi-cellular architecture, are not alleviated through the use of complex scaffolds produced
by AM (Mironov et al. 2009a). One promising advance that offers the potential to overcome
these limitations is cell printing technology.

Cell printing can be described as the use of material transfer processes to pattern and
assemble cells and biomaterials with a defined organisation (Mironov et al. 2006). It is one of
the most powerful combinations of TE with AM techniques that allows the production of 3D
tissues constructs, where multiple cell types and biomaterials can be directly placed in
specific spatial arrangements. Biomaterials have typically been hydrogels which, by virtue of
their high water content, are generally biocompatible, and often utilise gentle
crosslinking/gelation mechanisms that facilitate cell encapsulation with minimal adverse
effects on cell viability. The design of hydrogel biomaterials for TE and biofabrication
applications (Brandl et al. 2007; Drury and Mooney 2003; Hunt and Grover 2010; Lee and
Mooney 2001; Nicodemus and Bryant 2008; Seliktar 2012; Slaughter et al. 2009; Ulijn et al.
2007) is a broad area of research that will not be covered extensively here. Printing can
facilitate cell deposition either in organotypic architectures to engineer functional tissues, or
in cellular microarrays where individually addressable micro-cultures contain cells in a
physiologically relevant microenvironments (Fig. 1). The work of Klebe and co-workers
(Klebe 1988) in ‘cytoscribing’ laid the foundation for the precise patterning of living cells on
surfaces, but it was the more recent advances in AM and CAD/CAM that have seen the
advent of several bioprinting technologies that can actually deposit living cells. Several
reports outline progress in cell printing to date (Binder et al. 2011; Burg and Boland 2003;
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Calvert 2007; Campbell and Weiss 2007; Derby 2012; Guillemot et al. 2010a; Guillotin and
Guillemot 2011; Mironov et al. 2006; Wüst et al. 2011; Xu et al. 2011b).

In this review, we have outlined the general principles, current progress, and compared the
advantages and challenges for the most widely used biofabrication techniques for printing
cells: extrusion, laser, microvalve, inkjet and tissue fragment printing. We have particularly
focussed on bio-inks used to suspend cells for printing and the methods employed for
fabricating 3D structures.

Extrusion printing
General principle. Extrusion printing refers to techniques where continuous filaments of a
material are forced through a nozzle in a controlled manner to construct a 3D structure. For
extrusion printing of cells, the material usually consists of a highly viscous cell-laden
hydrogel (Fedorovich et al. 2007) that can flow from the nozzle without the need for high
temperatures. Once deposited, solidification of the hydrogel through physical or chemical
means provides sufficient mechanical integrity to fabricate 3D structures. The printer design
is generally simple, consisting of a 3-axis robot that controls the movement of either
pneumatically or volumetrically driven displacement pens or syringes with a typical nozzle
diameter of 150-300 µm. The utilisation of extrusion approaches for cell printing have
recently been reviewed (Chang et al. 2011; Fedorovich et al. 2007; Wang et al. 2010; Wüst et
al. 2011).

Current progress. Williams and co-workers were the first to report on the use of an extrusion
printer to deposit living cells (Smith et al. 2004). Using a commercial printer, they deposited
cold (2 - 10 °C) solutions of either human fibroblasts encapsulated in Pluronic-F127, or

5

bovine aortic endothelial cells (BAECs) in type I collagen, onto heated substrates where
solidification of the printed structures was induced by thermal gelation of the biopolymers.
The low temperatures used in this work and problems with dehydration of printed filaments
have resulted in low cell viabilities, although BAECs printed in collagen from a 250 µm tip
maintained 86% viability and were shown to proliferate over 24 hr. Importantly, this work
showed that CAD/CAM technology could be used to deposit cell laden structures that
mimicked an anatomical vascular structure. In follow-up work the viability of rat
microvascular cells printed in collagen as a function of several process parameters was
assessed (Smith et al. 2007).

Several groups have printed cells encapsulated in a range of hydrogels that are solidified
through either thermal processes or by post-print crosslinking, to engineer diverse tissues
ranging from liver to bone.

For example, Wang et al developed extrusion printing

approaches for the biofabrication of liver constructs (reviewed in Wang et al. 2007). They
used a custom-build printing system to deposit printed primary rat hepatocytes encapsulated
in materials including gelatin (Wang et al. 2006), gelatin/chitosan (Cheng et al. 2008; Yan et
al. 2005), gelatin/alginate (Yan 2005) and gelatin/fibrinogen (Xu et al. 2007). Structures were
deposited at low temperature (< 10 °C) onto a warmer stage, with the thermal gelation of
gelatin providing initial structural support, which was stabilised by immersion of the
construct in a solution containing a crosslinking agent or polymerising enzyme:
glutaraldehyde for gelatin; sodium tripolyphosphate for chitosan; calcium chloride for
alginate; thrombin for fibrinogen. These approaches showed good cell survival and retention
of metabolic function, although the use of harsh crosslinking conditions is a concern, and
vascularisation of the constructs remained a challenge (Wang et al. 2010).
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Subsequently this research group demonstrated that adipose-derived stem cells (ASCs)
printed in gelatin/alginate/fibrinogen gels could be induced to differentiate into endothelial
cells at the walls of printed channels (Xu et al. 2009a). They also showed that simultaneous
deposition of hepatocytes in gelatin/alginate/chitosan and ASCs in gelatin/alginate/fibrinogen
facilitated the fabrication of complex 3D structures mimicking the liver (Li et al. 2009) (Fig.
2).

The research of Fedorovich and co-workers has focussed on engineering bone and cartilage
constructs using a commercial extrusion printer (EnvisionTec, Germany) (Fedorovich et al.
2011a). In early studies, multi-potent stromal cells (MPSCs) from goat bone marrow were
deposited in both Lutrol F127 and alginate hydrogels, with gelation induced by thermal
changes and ionic crosslinking with calcium chloride, respectively (Fedorovich et al. 2008).
Cell viability was shown to be unaffected by the printing process, and in alginate constructs
(but not Lutrol F127 constructs) cells survived over time in culture with some evidence of
osteogenic differentiation. Additional investigations of both human and goat MPSCs in
printed alginate constructs showed that the enhanced diffusion of nutrients and oxygen to
encapsulated cells, afforded by the engineered porosity, enhanced cell viability and reduced
apoptosis and hypoxia in comparison with cells in solid alginate constructs when assessed
both in vitro and in vivo (Fedorovich et al. 2011b). However, only a fraction of cells in either
construct differentiated towards an osteogenic lineage.

Multiple-cell-type constructs were then fabricated to incorporate goat endothelial progenitor
cells (EPCs) in an effort to improve the engineered bone grafts and encourage vascularisation
(Fedorovich et al. 2011d). Both heterogeneous Matrigel/Matrigel constructs (EPCs and
MPSCs both in Matrigel™), and Matrigel/alginate constructs (EPCs in Matrigel™, MPSCs in
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alginate) were fabricated and implanted in vivo. In each case, the alginate or Matrigel
component containing MPSCs was supplemented with osteo-inductive biphasic calcium
phosphate (BCP) particles. After 6 weeks in vivo, Matrigel/BCP constructs demonstrated
considerable bone formation in the MPSC-laden Matrigel that was enhanced by the BCP
particles, and vascularisation in the EPC-laden Matrigel. There was little bone formation or
vascularisation in alginate constructs, however, which was attributed to the lack of cell
interaction and migration in alginate. A similar lack of cell interaction and function was
observed for human MSCs and articular chondrocytes encapsulated in alginate in multi-cell
fabricated osteochondral grafts (Fedorovich et al. 2011c).

In all of the work summarised above, a common problem was a lack of mechanical integrity
in the printed hydrogel constructs. This limited the scale and fidelity of the constructs, and
also posed challenges for implantation and the retention of the fabricated structure in vivo.
Recently, several reports have introduced approaches where extrusion printing of soft, cellladen hydrogels is combined with extrusion printing of stiffer, structural synthetic polymers.
For example, Schuurman et al demonstrated sequential printing of polycaprolactone (PCL)
and cell-laden alginate (Schuurman et al. 2011). The alginate component was crosslinked
with calcium chloride following deposition. Only a slight decrease in viability of a human
chondrocyte cell line deposited in the alginate was observed after 24 hr, and was likely due to
heat shock from the PCL printed adjacent to it (deposited at 160 °C). A very similar approach
was adopted by Kim et al, who used a custom multi-head dispensing system (Kim and Cho
2009) to deposit hybrid constructs containing a PCL/PLGA blend as the structural polymer
alongside collagen containing pre-osteoblast cells (Shim et al. 2011). In contrast, He et al
took a different approach to this problem with a ‘cryo-printing’ technique (He and Wang
2011). They printed ASCs in gelatin/alginate/fibrinogen containing a cryo-protectant (DMSO
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or glycerol) alongside polyurethane in a cell-compatible organic solvent (tetraglycol), both at
-20 °C. The constructs were then stored at -80 °C for one week before thawing and
crosslinking the gel component. They observed high cell viability (up to 75%) and the cells
proliferated over 14 days in culture.

Sun et al developed a novel bioprinting tool comprising four separate nozzles, each with a
different mode of deposition (Khalil et al. 2005). They used one of these, a pneumatic
microvalve nozzle in extrusion mode, to fabricate constructs with rat heart endothelial cells
encapsulated in alginate hydrogels by deposition of filaments directly into a thin layer of
calcium chloride solution (Khalil and Sun 2009; Khalil and Sun 2007). Subsequent reports
from this group have focused on developing mathematical models of the forces experienced
by cells during cell printing (Yan et al. 2010), and probing their effect on the viability of
extruded hepatocytes (Chang et al. 2008) and endothelial cells (Nair et al. 2009).

Laser-assisted bioprinting
General principle. Laser based approaches were among the pioneering works in cell printing.
Odde et al developed the “laser guidance direct write technique” (Odde and Renn 1999),
where a weakly focused laser beam acts as an optical trap that can control the movement of
particles in a solution. This was used to pattern living cells on a substrate (Odde and Renn
2000), and has been explored for layering multiple cell types (Nahmias et al. 2005) and
positioning of cells in microarrays (Ma et al. 2011). However, the technique is limited by low
throughput, low cell viability and a narrow range of fabricated structures and thus has not
been explored extensively as a biofabrication approach.
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By far the most productive application of laser-based printing techniques has been
approaches based on the principle of laser-induced forward transfer (LIFT). This technique
was initially developed for the direct writing of metal features using a high-energy pulsed
laser to deposit a metal film on an optically transparent support (Bohandy et al. 1986).
Modifications of the LIFT technique to deposit biological materials, including cells, have
collectively been described as laser-assisted bioprinting (LAB) techniques (Schiele et al.
2010b). The three key components of any LAB technique are a pulsed laser source, a target
plate usually made of quartz and coated with the ink to be printed (the ribbon), and a
receiving substrate that faces the ribbon (Fig. 3A). There have been two widely employed
variations of the LAB approach, which are distinguished by the nature of the ribbon. In
matrix-assisted pulsed laser evaporation – direct write (MAPLE-DW), the ribbon is coated
with a sacrificial biopolymer hydrogel (Fig. 3B) which acts as an attachment layer for cells
and absorbs the laser, typically a low powered pulsed laser in the UV or near-UV region.
Volatilisation at the ribbon-biopolymer interface induces cavitation which generates a high
speed (20 - 100 ms-1) jet that transfers a small volume of the biopolymer and cells to the
substrate. In contrast, biological laser printing (BioLP™), which is also referred to as
absorbing film assisted-LIFT (AFA-LIFT), uses a ribbon with a thin (1 - 100 nm) metal or
metal oxide (usually Au, Ti or TiO2) layer to absorb a high-powered laser pulse (Fig. 3C).
Due to rapid thermal expansion of this layer, a small volume of the ink is propelled to the
substrate as before, but with little transfer of the laser energy to the ink solution. In this
approach, cells can be coated onto the ribbon in either cell culture media or a biopolymer
hydrogel.
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Recent reviews provide both a broad overview of LAB in the context of other biofabrication
technologies (Guillemot et al. 2011; Guillotin and Guillemot 2011), as well as detailed
summaries of the development of each of these LAB techniques (Schiele et al. 2010b).

Current progress. Chrisey et al first demonstrated the MAPLE-DW technique and its ability
to pattern biomaterials including poly(ethylene glycol), enzymes and Chinese hamster ovary
(CHO) cells (Wu et al. 2001), as well as bacteria (Ringeisen et al. 2002) and proteins.
Further work enhanced the cell printing capabilities, showing that various cell types including
human osteosarcoma and rat cardiac cells (Barron et al. 2004b, Ringeisen et al. 2004), could
be printed with viability approaching 100% at near single-cell resolution using Matrigel™ as
the absorptive layer. At the same time, this group developed the improved BioLP™ approach
in an attempt to limit direct interaction between the laser and sensitive biomaterials (Barron et
al. 2004a). This technique also proved capable of depositing highly viable human
osteosarcoma cells (Barron et al. 2005) and olfactory ensheating cells (Othon et al. 2008)
onto Matrigel™ substrates.

Since this initial work, both MAPLE-DW and BioLP™ approaches have been implemented
with a range of ink materials and cell types, with increasing sophistication of printed
constructs. For example, Guillemot et al demonstrated printing of human endothelial cells
from an alginate ink as well as deposition of nano-particulate hydroxyapatite (nHAp) by
BioLP™ (Guillemot et al. 2010b). They subsequently showed that sequential deposition of
nHAp alongside human osteoprogenitors in alginate onto Matrigel™ substrates could be used
to pattern these components in 2D and 3D with retention of cellular function for application
in bone TE (Catros et al. 2011). Deposition of nHAp alongside osteoblast-like cells has also
been demonstrated by a MAPLE-DW approach (Doraiswamy et al. 2007).
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Chichkov and co-workers demonstrated that BioLP™ can be applied to reactive printing
approaches. For example, both human adipose-derived stem cells (ASCs) and endothelial
colony-forming cells (ECFCs) were printed sequentially from an ink mixture containing
hyaluronic acid (HA) and fibrinogen, onto a substrate sprayed with thrombin to crosslink the
printed material (Gruene et al. 2011b). This process could be repeated to construct, layer-bylayer, 3D arrays of encapsulated cells for the study of cell-cell and cell-material interactions.
Similarly, mesenchymal stem cells (MSCs) were encapsulated in hydrogels by printing them
from an alginate ink onto substrates coated with CaCl2, and the MSCs were subsequently
differentiated towards osteogenic or chondrogenic lineages (Gruene et al. 2011a). Sequential
layer-by-layer printing of fibroblasts and keratinocytes from collagen or alginate based inks
onto a Matriderm™ (dermal membrane) substrate with or without CaCl2 was also shown to
allow BioLP fabrication of skin-like 3D constructs (Koch et al. 2012).

Several recent reports have demonstrated BioLP of cells onto scaffolds pre-formed via other
fabrication techniques. For example, Chichkov et al used it to achieve selective seeding of
acrylated PEG scaffolds with ovine vascular smooth muscle cells and endothelial cells
printed from alginate-based inks (Ovsianikov et al. 2010). The same group also reported
printing HUVEC and human MSCs onto polyester composite cardiac patches which they
implanted in infracted rat hearts to yield functional improvement (Gaebel et al. 2011).
Another approach has been to BioLP cells onto thin bio-papers, which are subsequently
stacked to form 3D structures. For example, osteosarcoma cells were printed from an
alginate-based ink onto electrospun polycaprolactone (PCL) mats which were stacked
together (Catros et al. 2012). A parallel study outlined BioLP of HUVECs from a methylcellulose ink onto porous poly-lactide-co-glycolide films filled with collagen or Matrigel, and
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subsequent stacking of cell-laden layers (Pirlo et al. 2012). In a novel approach, Corr and coworkers used a MAPLE-DW approach with a gelatin-based ink to print human dermal
fibroblasts (Schiele et al. 2010a) as well as mouse embryonic stem cells that retained their
pluripotency (Raof et al. 2011). The advantage of the gelatin ink is that it melts and is
removed during culture so that the printed cells then have access to an application-specific
growth substrate, which in these reports was demonstrated with poly-L-lysine (PLL) surfaces.

Microvalve printing
General principle. Microvalve printing is a simple droplet-based deposition mechanism
where fluids under constant pneumatic pressure are dispensed from tips by opening and
closing a small valve, which can be controlled mechanically, electrically or magnetically.
This style of deposition has been implemented in extrusion-style printing as outlined above,
where the microvalve remains open for extended periods, but finds most application in dropon-demand deposition by fast actuation of the microvalve. The tips are usually 100-200 µm
in diameter, and are capable of dispensing droplets with volumes ranging from tens of nanolitres to several micro-litres, from inks with relatively low viscosities (1-20 mPa.s).

Current progress. The deposition of living cells using microvalve dispensing systems was
first explored by Demirci and Yoo (Demirci and Montesano 2007), who developed a custom
printing tool where four of these dispensers were mounted above a three-axis robotic stage
for use in cell printing. They demonstrated the fabrication of cell-laden collagen constructs by
a modified reactive printing process (Lee et al. 2009b; Lee et al. 2009a). Two dispensers were
used to print sequential layers of cells in culture media, and an acidic collagen solution. After
printing each layer of collagen, gelation was induced through a pH change by spraying the
construct with sodium bicarbonate using a nebuliser, before deposition of the cells onto the
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gelled collagen. In this manner, skin constructs containing human dermal fibroblasts and
epidermal keratinocytes (Lee et al. 2009a), as well as neural constructs containing embryonic
rat astrocytes and neurons (Lee et al. 2009b), were printed with high cell viability.

It was also shown that channels suitable for media perfusion could be included in these
constructs by printing sacrificial gelatin channels, and that perfusion enhanced the viability of
encapsulated fibroblasts (Lee et al. 2010). Since cells are suspended in culture medium in this
approach, cell settling and aggregation led to variations in cell output and clogging of
nozzles. In subsequent work, rat bladder smooth muscle cells were encapsulated in cold, preneutralised collagen solutions which could be microvalve printed and solidified by thermal
gelation with only a slight decrease in cell viability (Xu et al. 2010). Three-dimensional
patches containing encapsulated cells were fabricated in a layer-by-layer process, although 5
min equilibration at 37 °C was required after each printed layer to induce gelation (Moon et
al. 2010). Microvalve cell deposition has also been explored in the fabrication of constructs
tailored for in vitro studies, for example, co-cultures were printed onto Matrigel surfaces to
act as a model for the study of ovarian cancer (Xu et al. 2011a) and single mouse embryonic
stem cells were also deposited in microarrays for RNA analysis (Moon et al. 2011).

Robotic spotting technologies have been widely implemented in the fabrication of
microarrays where antibodies, DNA, proteins or other biomaterials are typically deposited
onto glass slides by contact pin-style printers (Anderson et al. 2005; Anderson et al. 2004;
Flaim et al. 2005). While this style of printing can be used to print microarrays of fixed cells
(Hart et al. 2009), it is not suitable for live-cell deposition. Dordick and co-workers have used
non-contact spotters, which utilise microvalve dispensing tips, to produce live cell microarray
platforms (Fernandes et al. 2009). Their approach is based on the deposition of individual
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droplets of cells suspended in a hydrogel matrix onto functionalised glass slides to create
stable pseudo-three dimensional arrays of encapsulated cells (Lee et al. 2008) (Fig. 4). Glass
slides were coated with poly(styrene-co-maleic anhydride) (PS-MA) to enhance
hydrophobicity, and spots of poly-L-lysine (PLL) containing BaCl2 were printed onto the
surface and dried. Cells suspended in alginate are then deposited directly on these first spots.
the PLL encourages adhesion of the alginate by ionic interaction, and the Ba2+ ions diffuse
through the alginate solution to crosslink it, forming a cell encapsulating hydrogel spot. In the
first demonstration of this approach, breast cancer and human hepatoma cell lines were
deposited in alginate spot microarrays and interrogated with a complimentary array slide
loaded with drugs or enzymes (Lee et al. 2008).This method was also employed to develop
an immunofluorescence based array to investigate the response of alginate-encapsulated
human pancreatic tumour cells to chemically-induced hypoxia (Fernandes et al. 2008). The
microarrays were also utilised to study the expansion and neural commitment of mouse
embryonic stem cells (Fernandes et al. 2010).

Inkjet printing
General principle. Inkjet printing is a non-contact technique capable of reproducing digital
image data on a substrate using picolitre ink droplets. The technique can be divided into two
broad categories: continuous inkjet (CIJ), where a steady stream of small droplets produced
by fluid instability on passage through a nozzle is either deflected by an electrostatic field
onto a substrate or not deflected and collected for reuse and drop-on-demand (DOD) inkjet,
were ink droplets are only produced when required. DOD inkjet is further categorised by the
mechanism used to produce the ink droplets. In thermal inkjet printing, rapid local heating
generates a bubble within the ink chamber that ejects a small droplet. Conversely, in
piezoelectric inkjet printing, the voltage-mediated actuation of a piezo-crystal is used to

15

create a pressure pulse resulting in droplet ejection. Static electricity actuated print heads
comprise a third ejection mechanism but are far less common. CIJ requires electrically
conducting ink formulations, and contamination concerns on ink re-cycling all but rule out
the technique for cell printing. Consequently only DOD inkjet has been utilised in cell
printing to date.

The foundational work of Klebe et al. (Klebe 1988) ‘cytoscribing’ with inkjet printers in
1988 could be considered the birth of bioprinting. Later, inkjet was introduced as a noncontact alternative to traditional contact pin arrayers for the deposition of biological materials
in microarray fabrication (Lemmo et al. 1998; Sumerel et al. 2006; Zaugg and Wagner 2003).
These instruments were expensive and limited to commercial microarray fabrication. At the
same time, however, the development of thermal inkjet technology by Hewlett-Packard and
Canon enhanced the accessibility of the inkjet approach by producing cheap and readily
available desktop printers. Research in cell printing has since utilised these readily available
technologies, and several reviews have outlined the use of inkjet printing in tissue
engineering and biofabrication applications (Binder et al. 2011; Boland et al. 2006; Burg et
al. 2010; Calvert 2007; Campbell and Weiss 2007; Derby 2009; Derby 2008).

Current progress. The use of inkjet printing technology to deposit living cells was first
explored by Wilson and Boland (Wilson and Boland 2003). Their printer was based on a
standard Hewlett-Packard (HP) printer housing, but for cell deposition they utilised a
specially designed print head containing 9 individual piezoelectric pumps connected to
needles (~ 160 µm internal diameter) that deposited relatively large (~ 15 nL) droplets. It was
demonstrated that bovine aortic endothelial cells (BAECs) and smooth muscle cells in cell
culture media could be deposited onto collagen or Matrigel™ substrates (Wilson and Boland
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2003). In follow-up research with Mironov and Markwald, aggregates of BAECs were
printed onto collagen and thermo-reversible gels in a layer-by-layer fashion, and closely
spaced aggregates showed evidence of tissue fusion (Boland et al. 2003). Although this
approach lacked the resolution that true inkjet printing could offer, it became the foundation
for the tissue fragment printing approach discussed in the next section.

Boland and co-workers were the first to show that viable mammalian cells could be deposited
from standard commercial thermal inkjet print heads (Xu et al. 2005). Using HP print heads
with a relatively large nozzle size (~ 50 µm) and drop volume (~ 80 pL), CHO cells and
embryonic rat motor neurons were deposited onto soy agar and collagen substrates. Primary
neural cells printed onto collagen were subsequently shown to exhibit normal
electrophysiology (Xu et al. 2006a). In these reports, though, cells were suspended in a
concentrated phosphate buffered saline (PBS) ink, which aided passage through the print
head as a result of cell contraction, however a significant portion of cells were lysed (~ 15%).
Later work investigated further the viability of CHO cells printed from a 1x PBS ink and
indicated that relatively high cell viability was maintained (89%), with only a small number
of apoptotic cells (~ 3.5%) (Cui et al. 2010). It was found that the thermal inkjet printing
process generated small (~ 100 Å) transient pores in cell membranes that self-repaired within
2 hr of printing and, interestingly, this phenomenon could be applied to transfect plasmid
DNA into CHO cells (Cui et al. 2010) and endothelial cells (Xu et al. 2009c) during printing.

Burg and co-workers have investigated some fundamental aspects of inkjet cell printing that
are key checkpoints in the development of the technology towards becoming a clinically
relevant biofabrication tool. Having recognised that printing salt-containing solutions through
thermal inkjet heads can quickly lead to nozzle failure due to salt crystallisation, the chelating
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agent ethylenediaminetetraacetic (EDTA) was included in a culture media ink in an attempt
to extend print head lifetime (Parzel et al. 2009). This approach was successful in enhancing
throughput, although there was some evidence of reduced cell viability after longer (~ 30
min) exposure times to the EDTA-containing ink. The group has also thoroughly
characterised the adverse effects of cell settling and aggregation on cell output during
printing, noting that the reproducibility of cell deposition is affected after ~ 10 mins (Pepper
et al. 2012b; Pepper et al. 2011). Co-cultures of D1 murine mesenchymal stem cells and 4T07
murine mammary cancer cells were deposited on collagen hydrogel substrates (Burg et al.
2010) and the group has developed novel methods to achieve alignment of multiple print
heads (Burg et al. 2010), retain printed pattern fidelity and viability through various postprocessing methods (Pepper et al. 2010), and quantitatively analyse the fidelity of printed
patterns (Pepper et al. 2012a).

Boland et al. explored reactive printing approaches to encapsulate inkjet printed cells in 3D
hydrogel structures, using both alginate/calcium and fibrin/thrombin reactive systems. Cellcontaining fibrin channels that mimicked simple vasculature were fabricated by suspending
human microvascular endothelial cells in 1xPBS solution containing thrombin and calcium
chloride, and printing onto thin layers of fibrinogen (Cui and Boland 2009). While cells were
not directly printed in the following approach, alginate solutions containing cells were also
selectively cross-linked by the inkjet deposition of calcium chloride to create
cell-encapsulating hydrogels with defined three-dimensional structure (Boland et al. 2007;
Xu et al. 2009b).

These reactive printing approaches were pursued further by Atala and Xu by suspending cells
in a calcium chloride solution, followed by printing into an alginate/collagen mixture (Xu et
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al. 2008b; Xu et al. 2006b). In this way, hydrogels containing regions patterned with multiple
cell types could be fabricated (Xu et al. 2006b). Printed cell-laden constructs were also
implanted in mice and monitored by magnetic-resonance imaging (MRI) (Xu et al. 2008b; Xu
et al. 2006a), revealing changes in tissue microvasculature. The reactive process was also
reversed, with cells suspended in low viscosity alginate solutions and printed in a calcium
receiving bath; this was used to create single droplets of alginate hydrogels encapsulating
pancreatic islet cells that continued to produce insulin (Xu et al. 2008a).

The approach of printing low viscosity alginate solutions containing cells into calcium
chloride receiving baths has also been investigated by Nakamura and co-workers. This group
used inkjet print heads that eject ink droplets by actuation of the ink chamber via static
electricity (SEAjet™, Seiko EPSON). Having demonstrated that the print heads could deposit
cells (Nakamura et al. 2005), HeLa cells were encapsulated in 3D alginate hydrogels by this
reactive printing approach (Nakamura et al. 2006). In further work, the quality of the printed
structures was improved by including viscosity enhancers such as PVA into the receiving
bath and employing a high calcium chloride concentration, although this reduced cell
viability to ~ 70% (Nishiyama et al. 2009). In a more recent report, this reactive printing
approach was reproduced with a custom piezoelectric inkjet head containing four separate
nozzles (Arai et al. 2011), although cell viability was not thoroughly investigated.

There have been only a few other examples of cell deposition by piezoelectric inkjet printing,
and until recently these used single nozzle systems. Derby et al. printed human fibroblast
cells using a commercial single nozzle (60 µm diameter) piezoelectric ejector (Microfab Inc.,
USA) (Saunders et al. 2008). Importantly, this was the first report to conduct a
comprehensive study on the viability of inkjet printed cells. Additionally, control over the
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actuation waveform used to drive the piezoelectric deposition allowed analysis of the effect
of forces applied to cells during printing on their subsequent behaviour. Cell survival was
high (> 90%) in all cases, with a slight reduction in viability with increasing actuation voltage
(98% at 40V, 94% at 80V), and was indistinguishable from control cells under optimal
printing conditions. This printer was also used to deposit cells into micro-well compartments
pre-fabricated by inkjet printing of a novel ink material combining thermal and photoinitiated crosslinking mechanisms (Di Biase et al. 2011). Derby has also been instrumental in
highlighting to the cell printing community the requirements for printable inkjet fluids (Derby
2010).

Parsa et al. used single piezoelectric nozzle ejectors (60-100 µm diameters, Microdrop
Technologies, Germany) to print hepatocytes from a surfactant-containing ink. They found
that although initial cell viability was high, it decreased after 7 days in culture (Parsa et al.
2010). The authors were unable to determine of this was a result of the printing process, the
added surfactant, or other factors. This work also employed gentle agitation of the print head
in an effort to reduce cell settling and aggregation, although this led to reduced cell viability.
Liberski et al used the same nozzle ejector to fabricate living cell microarrays by combining
deposition of cell-laden droplets with novel water-in-oil emulsion cell culture (Liberski et al.
2011).

Recently, two research groups have successfully addressed one of the main challenges of cell
printing: preventing the settling and aggregation of cells, whilst meeting the stringent fluid
property requirements. Chahal et al. successfully addressed this issue by using a surfactant
(Ficoll-PM 400) to control the ink density resulting in reliable cell printing through a
commercial single nozzle (MicroFab, Germany) over 90 min (Chahal et al. 2012). Ferris et al
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showed that a bio-ink based on a novel microgel suspension in surfactant-containing tissue
culture media could be used to prevent cell settling and aggregation (Ferris et al. 2013). The
stable suspension and optimal fluid properties of the bio-ink allowed reproducible printing of
several different cell types, from two different commercially available drop-on-demand
printing systems, over long printing periods. They demonstrated (Fig. 5) that two cell types
(C2C12 and PC12) could be printed simultaneously from two different commercial inkjet
print heads (each with 126 nozzles) in defined two-dimensional patterns onto collagen
hydrogel substrates. Printing multiple cell types from different print heads is a highly
attractive feature of inkjet printing as a biofabrication tool, allowing the fabrication of more
complex multi-cellular constructs.

Tissue fragment printing
General principle. The combination of bioprinting techniques with biological self-assembly
is an approach to fabricating tissue structures that has been developed over the last decade.
Founded on the dictum that ‘nature knows best’, and drawing from the principles of
developmental biology, this approach exploits the intrinsic capacity of closely spaced tissue
fragments to fuse together; otherwise known as ‘tissue fluidity’ (Forgacs et al. 1998). Tissue
fragments, often spheroids containing several thousand cells, are deposited in close spatial
organisation so that they fuse together to generate an organotypic structure. In many ways,
this could be viewed as a distinct bioprinting concept, rather than just an alternate bioprinting
method. It has been the subject of several topical reviews and opinion pieces (Jakab et al.
2010; Marga et al. 2012; Mironov et al. 2009b; Mironov et al. 2007; Mironov et al. 2006).
The technique has historically been termed ‘organ printing’.
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Current progress. This bioprinting approach was proposed in 2003 (Mironov et al. 2003)
following the development of the first cell printer by Boland and Wilson (Boland et al. 2003).
The following year saw the development of techniques used to obtain reproducible spherical
aggregates of CHO cells (~ 500 µm in diameter) by controlled cutting of tissue cylinders
(Jakab et al. 2004b), and the fusion of these CHO aggregates after manually positioning
within cell-responsive gels was demonstrated (Jakab et al. 2004b; Jakab et al. 2004a).

Concomitantly, various bioprinting tools were being developed for the extrusion printing of
living cells. It was shown that CHO aggregates could be aspirated into a capillary and then
printed into defined assemblies surrounded by collagen gel using a commercial mechanical
bio-assembly tool (nScrypt, USA). This approach was also applied to the fabrication of
cardiac constructs from aggregates of embryonic cardiac and endothelial cells (Jakab et al.
2008). The process was refined further, through the development of a specifically designed
bioprinter and alterations to existing printing methods (Norotte et al. 2009). Specifically, it
was recognised that the use of collagen gels limited the fabrication of 3D structures due to
premature gelation and unwanted integration with the fusing aggregates. Collagen was
therefore replaced with bio-inert agarose gels, and branched vascular structures were
fabricated from spheroids of human skin fibroblasts (HSFs) (Fig. 6A-C). Without suitable
methods to upscale the fabrication of tissue spheroids and reproducibly aspirate them into a
capillary, however, this approach was cumbersome and limited to small structures.
Furthermore, the fusion of tissue aggregates was a slow process and could lead to distortion
of the printed constructs (Norotte et al. 2009). Consequently, an alternative approach was
demonstrated where long cylindrical tissue aggregates were matured and strengthened in
agarose moulds before aspiration into capillaries and deposition in 3D arrangements (Fig.
6D-F). This approach was utilised to fabricate vascular tubes from human umbilical vein
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smooth muscle cells (HUVSMCs) and HSFs (Norotte et al. 2009), and preliminary results
have been reported on the fabrication of nerve grafts containing Schwann cells (SCs) (Marga
et al. 2012).

Comparison of approaches and remaining challenges
The selection of a particular biofabrication approach for assembling a cell-laden structure is
dependent on the desired geometry (i.e. 2D or 3D). This in turn is largely dictated by the
performance of each biofabrication method in terms of amount of material deposited and
precision/repeatability of positioning. Based on these two criteria it is reasonable to assume
that extrusion printing methods are more suitable for fabricating 3D structures, whereas dropon-demand techniques (e.g. inkjet printing) are more amenable for fabricating 2D structures
and for the precise placement of cells within engineered constructs. The suitability of each
biofabrication method (as reviewed in this article) for assembling 2D and 3D structures has
been outlined in more detail in what follows.

Extrusion printing could be considered the simplest of all the approaches described here, and
is arguably the most amenable to the production of 3D hydrogels given that cells can be
encapsulated within a hydrogel ink prior to deposition. This could also be considered a
detriment, however, because it means that cells must be confined to a printable matrix; this
does not permit the separation of cell deposition and matrix deposition. Reliance on contact
with the substrate is not ideal and printing resolution is generally poor. The primary
drawback is that deposition is restricted to continuous filaments, which limits the scope of
fabricated structures. The advantage is that 3D structures, whether bulk solids or porous
architectures built by the familiar ‘log-pile’ stacking of filaments, can be fabricated relatively
quickly and simply. Drop-on-demand techniques are advantageous in that they employee
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digital fabrication capable of reproducing essentially any pattern or structure, although in
comparison to extrusion printing the fabrication of 3D structures can be more difficult as it
requires the coordinated coalescence and solidification of droplets.

Printing tissue fragments could be considered a drop-on-demand technique if cell spheroids
are deposited. This approach is attractive because cells within the tissue fragments are in a
physiologically relevant configuration with high densities and cell-cell contact, and because
natural developmental mechanisms are elicited. There remain, however, significant
challenges to this technique. The formation and processing of tissue spheroids is
cumbersome, and the alternative of extruding cylindrical tissue fragments limits fabrication
flexibility; it is no longer a drop-on-demand style approach and the scope of possible printed
architecture is diminished. Removal of agarose supporting rods can also be difficult with
more complex structures (Norotte et al. 2009). As with conventional extrusion printing,
resolution is generally poor. Cell aggregates are 300-500 µm in diameter, larger than the
diffusion limit of oxygen (100-200 µm), and therefore hypoxia is a concern, as evidenced by
the presence of apoptotic cells within printed vascular walls (Norotte et al. 2009).

The drop-on-demand techniques including laser, microvalve and inkjet printing boast good
resolution and flexibility. They are amenable to deposition of cells directly on a surface or, as
demonstrated for each technique, 3D structures can be fabricated using reactive printing or
layer-by-layer approaches. Each of these techniques incurs substantial technological hurdles.

The key advantage of LAB is that it is a nozzle-free approach, which allows printing of inks
with a wide range of viscosities (1-300 mPa.s), at concentrations up to 1x108 cells/mL,
without issues with nozzle clogging (Guillotin and Guillemot 2011). High resolution is
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possible and only a very small amount of material is required. However, laser techniques are
not as accessible or as well characterised as microvalve or inkjet printing. The process
requires ribbon preparation prior to printing and therefore non-uniform ink coating can cause
inconsistent cell output, and the thin layer of ink can dry quickly on the ribbon surface
(Schiele et al. 2010b). Printing speed and throughput is also limited and scale-up is difficult
(Guillotin and Guillemot 2011), which makes this technique more suitable for the fabrication
of 2D films, rather than 3D structures. The use of intense laser irradiation and its long term
effect on cells is a concern, although BioLP addresses this somewhat with the absorptive
interface layer. This layer presents additional problems, however, as cytotoxic metal and
metal oxide particles can be transferred to the printed material (Guillotin and Guillemot
2011), although this could potentially be avoided by replacing the metal layer with a
polyimide (Brown et al. 2010).

Microvalve printing allows simple drop-on-demand deposition that, in comparison with
inkjet printing, is not as dependent on the fluid properties of the ink (Derby 2010).
Importantly, control over microvalve actuation and the applied pressure means that the
deposited droplet volume can be easily adjusted across a wide range, which is not possible for
the other drop-on-demand techniques. The minimum droplet size is large and thus printing
resolution is poor compared to that of laser and inkjet printing, and this could prevent
fabrication of some organotypic structures. The capability to dispense larger volumes could,
however, allow faster fabrication of larger 3D structures. Although not as problematic as in
inkjet printing, cell aggregation and settling within the printer can alter cell output and clog
nozzles, especially when printing from CCM.
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Inkjet printing is arguably the most attractive bioprinting technique for positioning cells
within engineered constructs, providing a combination of non-contact, high-throughput
deposition with single cell resolution. Widespread implementation of inkjet in the consumer
graphics printing market has led to rapid development of the technology, which is now well
understood and highly accessible. Relationships between droplet generation and fluid
properties or printing parameters are thus well understood (Derby 2010). Furthermore, the
application of inkjet to colour printing, where several print heads are used to simultaneously
deposit different coloured inks, should be easily transferrable to the deposition of multiple
cell types, biomaterials and other biological factors; this has already been demonstrated to an
extent (Burg et al. 2010; Xu et al. 2006b). However, efficient inkjet printing is heavily reliant
upon the ink meeting a relatively stringent set of fluid property requirements (Derby 2010).
The issue of settling and aggregation of cells has recently been successfully addressed
(Chahal et al. 2012; Ferris et al. 2013). Furthermore, work to date has utilised thermal inkjet ,
single-nozzle piezoelectric, and multiple nozzle piezoelectric printheads (Ferris et al. 2013).
Piezoelectric heads are the industry standard for high end printing applications and could
provide advantages over thermal heads; primarily, a greater control over droplet formation
parameters (Derby 2010; Saunders et al. 2008). Long-term cell viability could be an issue due
to the high shear forces imposed during deposition, and further work is required to
characterise this further for both thermal and piezoelectric inkjet printing.

Conclusions
In conclusion, the development of cell printing is vital for establishing biofabrication
approaches as clinically relevant tools. Central to this is the design of the bio-inks, which
must be easily printable, allow controllable, reproducible printing of cells and have some
solidification mechanism to enable the fabrication of 3D structures. Crucially, this must be
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achieved without causing cell damage, and the final printing structure should support normal
cell function and the development of 3D engineered constructs that mimic normal tissues.

The cell printing techniques presented in this review provide alternative routes to controlled
cell deposition, with individual advantages and challenges which have been outlined. The
different approaches should be regarded as complimentary rather than competing
technologies. It is likely that significant advances in cell printing will be made through
synergistic combinations of these techniques in order to optimise resolution, throughput and
the overall complexity of printed constructs. For example, the use of printing approaches with
different resolutions could be employed to mimic aspects of natural biological systems
operating on different scales. Additionally, some work highlighted in this review has
demonstrated the merging of cell printing with solid scaffolds produced via other
biofabrication methods, and there is certainly scope to investigate these combinations further.
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Figure Captions
Fig. 1 Cartoon representing the concept of cell printing technology. A patient-specific
computer model of a jaw bone instructs the deposition of cells and biomaterials from a cell
printer to fabricate a tissue engineered replacement construct. Reproduced from (Campbell
and Weiss 2007).
Fig. 2 Sequential deposition of hepatocytes in gelatin/alginate/collagen (A, clear) and ASCs
in gelatin/alginate/fibrinogen (B, red) to produce a 3D liver construct (C). Adapted from (Li
et al. 2009).
Fig. 3 Schematic representation of the LAB approach (A), including the ribbon design
utilised in both MAPLE-DW (B) and BioLP (C) variations.
Fig. 4 3D cell microarrays produced by microvalve deposition of cell-laden alginate droplets
onto pre-printed BaCl2/ poly-L-lysine (PLL) spots on poly(styrene-co-maleic anhydride) (PSMA). Gelation of alginate droplets is mediated by Ba2+, and adhesion of the gel to the PS-MA
surface is enhanced through PLL. Adapted from (Fernandes et al. 2009).
Fig. 5 Patterning of two cell types printed simultaneously from two separate inkjet print
heads onto collagen substrates. (a) Schematic representation of multiple head printing. (b, c)
C2C12 (red) and PC12 (green) cells pre-stained with CellTrackerTM dyes and printed in
various patterns. Images were taken 1 hr after printing, following the addition of culture
media. (d, e) Printed patterns of C2C12 and PC12 cells after 8 days under differentiation
conditions. Cells were immunostained for desmin (C2C12, green) and β-III tubulin (PC12,
red). Dotted lines represent the outline of the original print pattern. Scale bars represent 500
µm (b-d) and 200 µm (e). Reproduced from (Ferris et al. 2013).
Fig. 6 Representative structures printed from tissue fragments, adapted from (Norotte et al.
2009). (A) Deposition scheme for a branched vascular structure from tissue spheroids. (B-C)
Branched structure built from 300 µm HSF spheroids initially (B), and fused 6 days after
deposition (C). (D) Deposition scheme for tube fabrication using tissue cylinders. (E-F)
Printed tubes from agarose cylinders and pig SMCs initially (E), and after fusion and removl
from agarose 3 days after deposition (F).

40

Figure 1

41

Figure 2

42

Figure 3

43

Figure 4

44

Figure 5

45

Figure 6

46

